yes, we all thought EPT are raising extra money to bring melanotan to market 100% themselves with no big pharma.
unfortunately in the open briefing, its not true, epitan said they are looking to bring melanotan to market in europe and USA with a PARTNER, so that means EPT will not get 100% of profit on sales, but only say 15% of sales if it goes in with a JV partner, like they intend too.
melanotan, page-3
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.25 |
Change
0.000(0.00%) |
Mkt cap ! $764.0M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | $15.32 | $15.22 | $38.89K | 2.585K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 276 | $16.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.75 | 67 | 1 |
View Market Depth
| Last trade - 09.57am 04/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |
Day chart unavailable